[Revascularization of coronary artery disease in diabetes mellitus].
Coronary artery disease in diabetes mellitus (DM) is still associated with a poor prognosis. Especially percutaneous coronary interventions (PCI) have a higher rate of complications and restenosis, so that surgical revascularization is usually favoured in DM. The development of drug-eluting stents has improved the results of PCI significantly, however, there are still not enough prospective data comparing them to bypass surgery. The present paper summarizes the current state of coronary revascularization.
2. Medizinische Abteilung, Krankenanstalt Rudolfstiftung, Wien, Osterreich.
Paul
P
Wexberg
Franz
F
Weidinger
D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000097:blood* / Q000401:mortality / Q000628:therapy*; D023903:Coronary Restenosis / Q000097:blood / Q000401:mortality / Q000628:therapy; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000401:mortality / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000097:blood* / Q000401:mortality / Q000628:therapy*; D054855:Drug-Eluting Stents; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D009204:Myocardial Revascularization; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human
Revaskularisation der koronaren Herzerkrankung bei Diabetes mellitus.